ZIMMER BIOMET HLDGS DL-01
ZIMMER BIOMET HLDGS DL-01/ US98956P1021 /
ZIM
|
2024-09-27 8:03:18 AM
|
Chg.
+0.160
|
Volume |
Bid11:27:26 AM |
Ask11:27:26 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
96.160EUR
|
+0.17%
|
-
Turnover: - |
96.240Bid Size: 300 |
97.000Ask Size: 300 |
19.62 bill.EUR |
- |
- |
Business description
Founded in 1927 and headquartered in Warsaw, Indiana, USA, Zimmer Biomet is a global leader in musculoskeletal healthcare. The company designs, manufactures and markets orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
Management board & Supervisory board
| CEO |
| Ivan Tornos |
| Management board |
| Suketu Upadhyay, Mark Bezjak, Rachel Ellingson, Nitin Goyal, David J. Kunz, Angela Main, Keri P. Mattox, Chad Phipps, Paul Stellato, Zeeshan Tariq, Kenneth R. Tripp, Lori Winkler, Sang Yi, Wilfred van Zuilen |
| Supervisory board |
| Christopher B. Begley, Betsy J. Bernard, Michael J. Farrell, Robert A. Hagemann, Ivan Tornos, Arthur J. Higgins, Maria Teresa Hilado, Syed Jafry, Sreelakshmi Kolli, Michael W. Michelson |
Company data
| Name: |
Zimmer Biomet Holdings Inc. |
| Address: |
345 East Main Street,Warsaw, Indiana 46580, USA |
| Phone: |
+1-574-373-3121 |
| Fax: |
- |
| E-mail: |
surveys@zimmerbiomet.com
|
| Internet: |
www.zimmerbiomet.com/ |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
12-31 |
| Free Float: |
74.90% |
| IPO date: |
2001-08-03 |
Company calendar
|
CW 40 | 2024-09-30
Ex-Dividend
|
|
CW 40 | 2024-09-30
Record Date
|
|
CW 44 | 2024-10-31
Dividend Payment
|
